PharmAust |
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 13 November 2026 at 8:05am | ||||
|
Market Cap (13-Nov) $111,926,056 (1,449th) |
Close (30-Jun) $0.075 |
Volume (30-Jun) 0 |
Shortsold (11-Oct) 108,089 (0.02%) (492nd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.02 |
Preliminary MPL antiviral leukaemia preclinical WEHI results
PAA released this announcement to the ASX on 23 February 2022, 11:13. The announcement is marked as price sensitive, and is 2 page(s) in length and 243.37kb in size.
You can view all announcements from PAA and see how they appear on a price chart on the announcements page.
At the date of this announcement, PAA was 0.072% short sold according to ASIC data. It was ranked the 487th most shorted stock on the ASX. It remains ranked 492nd as of the latest reported data (11 October 2024).
| Other Recent Announcements from PAA | |
|---|---|
| Results of General Meeting | 30 June 2023, 12:38 |
| Trading Halt | 30 June 2023, 9:48 |
| General Meeting - Chairman Script | 30 June 2023, 9:42 |
| Preliminary MPL antiviral leukaemia preclinical WEHI results | 23 February 2022, 11:13 |
| Key Appointment to Progress MPL COVID-19 Clinical Trial | 21 February 2022, 8:04 |
| Appendix 4D & Half Year Report | 18 February 2022, 17:53 |
| Epichem Confirms Effectiveness of OHD E-Waste Project | 16 February 2022, 8:10 |
If you were already registered, log in here.